Cannabidiol (CBD), the major non-psychoactive phytocannabinoid of Cannabis sativa L., is
one of the most studied compounds in pharmacotherapeutic approaches to treat oxidative …

Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder in the
world. Motor impairment seen in PD is associated with dopaminergic neurotoxicity in the …

Alzheimer's disease (AD) is a debilitating neurodegenerative disease characterized by
declining cognition and behavioral impairment, and hallmarked by extracellular amyloid-β …

We present the synthesis and characterization of merged human butyrylcholinesterase (h
BChE) inhibitor/cannabinoid receptor 2 (h CB2R) ligands for the treatment of …

Antibiotic resistance has become an increasing challenge in the treatment of various
infectious diseases, especially those associated with biofilm formation on biotic and abiotic …

Ferroptosis, a regulated form of cellular death characterized by the iron-mediated
accumulation of lipid peroxides, provides a novel avenue for delving into the intersection of …

The global increase in the aging population has led to a rise in many age-related diseases
with continuing unmet therapeutic needs. Research into the molecular mechanisms …

The oxytosis/ferroptosis regulated cell death pathway is an emerging field of research owing
to its pathophysiological relevance to a wide range of neurological disorders, including …

Cannabinol (CBN) is a non-psychoactive phytocannabinoid found in Cannabis sativa.
Although overshadowed by its more well-known counterparts, such as delta-9 …

Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of
dopaminergic neurons in the substantia nigra and the accumulation of α-synuclein …